SecSonar.com

Fortrea Holdings Inc. (FTRE)

Fortrea Holdings Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Fortrea Holdings Inc. (FTRE) is a Biotechnology company based in US with a market capitalization of $1.5B. Revenue grew 1.0% year-over-year and the company generated $88.3M in free cash flow. This page tracks FTRE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 15K employees · IPO Jun 20, 2023

Valuation

Valuation & price

$13.66 · as of May 17, 2026 · -25.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.60

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$18.40$11.42$4.45Jul 25Dec 25Jul 26Jul 7, 25$4.45Jul 9, 25$5.04Jul 11, 25$5.11Jul 15, 25$4.72Jul 17, 25$4.95Jul 21, 25$4.66Jul 23, 25$6.31Jul 25, 25$6.80Jul 29, 25$6.36Jul 31, 25$5.74Aug 4, 25$6.42Aug 6, 25$6.58Aug 11, 25$6.39Aug 13, 25$7.84Aug 15, 25$8.04Aug 19, 25$7.89Aug 21, 25$7.75Aug 25, 25$8.86Aug 27, 25$9.03Aug 29, 25$9.85Sep 3, 25$10.69Sep 5, 25$11.63Sep 9, 25$10.07Sep 11, 25$10.23Sep 16, 25$10.06Sep 18, 25$10.65Sep 22, 25$9.64Sep 24, 25$9.47Sep 26, 25$8.68Sep 30, 25$8.42Oct 2, 25$9.60Oct 6, 25$9.59Oct 8, 25$10.13Oct 10, 25$9.68Oct 14, 25$9.55Oct 16, 25$9.52Oct 21, 25$10.39Oct 23, 25$10.80Oct 27, 25$10.39Oct 29, 25$10.44Oct 31, 25$10.46Nov 4, 25$9.70Nov 6, 25$11.02Nov 10, 25$11.18Nov 12, 25$11.34Nov 14, 25$10.41Nov 18, 25$10.20Nov 20, 25$10.04Nov 25, 25$12.78Nov 28, 25$12.71Dec 2, 25$12.75Dec 4, 25$14.50Dec 8, 25$14.78Dec 10, 25$15.14Dec 12, 25$15.72Dec 16, 25$15.99Dec 18, 25$16.61Dec 22, 25$17.69Dec 24, 25$17.70Dec 29, 25$17.25Jan 2, 26$16.81Jan 6, 26$17.54Jan 8, 26$17.44Jan 12, 26$18.40Jan 14, 26$16.77Jan 16, 26$16.50Jan 21, 26$17.01Jan 23, 26$16.83Jan 27, 26$17.12Jan 29, 26$17.05Feb 2, 26$16.86Feb 4, 26$16.06Feb 9, 26$14.88Feb 11, 26$11.59Feb 13, 26$9.79Feb 18, 26$10.44Feb 20, 26$11.00Feb 24, 26$10.32Feb 26, 26$10.80Mar 2, 26$10.56Mar 4, 26$10.38Mar 6, 26$9.61Mar 10, 26$8.95Mar 12, 26$9.04Mar 17, 26$9.70Mar 19, 26$9.79Mar 23, 26$9.75Mar 25, 26$9.44Mar 27, 26$9.07Mar 31, 26$9.42Apr 2, 26$9.45Apr 7, 26$9.51Apr 9, 26$9.38Apr 13, 26$9.38Apr 15, 26$10.05Apr 17, 26$10.38Apr 22, 26$10.50Apr 24, 26$9.80Apr 28, 26$10.76Apr 30, 26$11.50May 4, 26$12.25May 6, 26$15.64May 8, 26$15.43May 12, 26$14.61May 14, 26$14.24May 18, 26$13.59May 20, 26$13.70May 22, 26$13.22May 28, 26$15.00Jun 1, 26$15.76Jun 3, 26$15.63Jun 5, 26$16.08Jun 9, 26$16.88Jun 11, 26$16.87Jun 15, 26$16.63Jun 17, 26$15.32Jun 22, 26$15.56Jun 24, 26$17.02Jun 26, 26$17.65Jul 2, 26$17.28
$4.4552-week range$18.40
Loading valuation history…

Fundamentals

Key fundamentals

$1.5B

Market cap

1.0%

Revenue growth (YoY)

15.6%

Gross margin

$88.3M

Free cash flow (USD)

-$106.6M

Net debt

Net cash position

1.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$2.6BFY 2021$3.1BFY 2022$2.8BFY 2023$2.8BFY 2024$2.7BFY 2025$2.7B
$2.6B$2.7B

Free cash flow by year

2020 → 2025

FY 2020$176.9MFY 2021$143.3MFY 2022$28.3MFY 2023$128.1MFY 2024$237.3MFY 2025$88.3M
$176.9M$88.3M

Gross margin by year

2021 → 2025

FY 202119.8%FY 202225.5%FY 202320.8%FY 202419.8%FY 202515.6%
19.8%15.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

4

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCFO AppointmentJun 26, 2026Filing
  • Insider sellInsider Sell $79KMorais Mark A. · Chief Operating Officer · $78.6KJun 12, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 12, 2026Filing
  • Insider sellInsider Sell $75KMcconnell Jill G. · Chief Financial Officer · $75.4KJun 3, 2026Filing
  • Insider sellInsider Sell $75KMorais Mark A. · Chief Operating Officer · $75.4KJun 3, 2026Filing
  • Insider sellInsider Sell $27KParks Robert · Chief Accounting Officer · $26.9KMay 20, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing

Questions

Frequently asked questions

What is Fortrea Holdings Inc.'s market cap?

Fortrea Holdings Inc. (FTRE) has a market capitalization of $1.5B.

What is FTRE's P/E ratio?

A meaningful P/E ratio is not available for FTRE — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is FTRE's price-to-book (P/B) ratio?

FTRE trades at 2.60 times book value per share.

Are insiders buying FTRE stock?

SEC Form 4 filings show no open-market insider buys at Fortrea Holdings Inc. in the last 90 days (4 sells).

Same arena

Related companies in Biotechnology

IMCR

Immunocore Holdings plc

$1.5B

TSHA

Taysha Gene Therapies, Inc.

$1.5B

MAZE

Maze Therapeutics, Inc.

$1.5B

IOVA

Iovance Biotherapeutics, Inc.

$1.4B

ARDX

Ardelyx, Inc.

$1.5B

INBX

Inhibrx Biosciences, Inc.

$1.5B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.